Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Recombinant human fibrinogen that produces thick fibrin fibers with increased wound adhesion and clot density.

Calcaterra J, Van Cott KE, Butler SP, Gil GC, Germano M, van Veen HA, Nelson K, Forsberg EJ, Carlson MA, Velander WH.

Biomacromolecules. 2013 Jan 14;14(1):169-78. doi: 10.1021/bm301579p. Epub 2012 Dec 18.

PMID:
23215461
2.
3.

A totally recombinant human fibrin sealant.

Carlson MA, Calcaterra J, Johanning JM, Pipinos II, Cordes CM, Velander WH.

J Surg Res. 2014 Mar;187(1):334-42. doi: 10.1016/j.jss.2013.09.039. Epub 2013 Oct 2.

PMID:
24169144
4.

Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.

Allan P, Uitte de Willige S, Abou-Saleh RH, Connell SD, Ariëns RA.

J Thromb Haemost. 2012 Jun;10(6):1072-80. doi: 10.1111/j.1538-7836.2012.04717.x.

5.

Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.

Cooper AV, Standeven KF, Ariëns RA.

Blood. 2003 Jul 15;102(2):535-40. Epub 2003 Mar 27.

6.

Resistance of gammaA/gamma' fibrin clots to fibrinolysis.

Falls LA, Farrell DH.

J Biol Chem. 1997 May 30;272(22):14251-6.

7.

Fibrin sealants in supporting surgical techniques: strength in factor XIII.

Phillips M, Dickneite G, Metzner H.

Cardiovasc Surg. 2003 Aug;11 Suppl 1:13-6. Review.

PMID:
12869983
8.

Specific effects of fibrinogen and the γA and γ'-chain fibrinogen variants on angiogenesis and wound healing.

Cheung EY, Weijers EM, Tuk B, Scheffer R, Leebeek FW, van Neck JW, Koolwijk P, de Maat MP.

Tissue Eng Part A. 2015 Jan;21(1-2):106-14. doi: 10.1089/ten.TEA.2014.0020. Epub 2014 Aug 5.

9.

Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing.

Domingues MM, Macrae FL, Duval C, McPherson HR, Bridge KI, Ajjan RA, Ridger VC, Connell SD, Philippou H, Ariëns RA.

Blood. 2016 Jan 28;127(4):487-95. doi: 10.1182/blood-2015-06-652214. Epub 2015 Nov 25.

PMID:
26608329
10.
11.

Pathophysiologic roles of the fibrinogen gamma chain.

Farrell DH.

Curr Opin Hematol. 2004 May;11(3):151-5. Review.

PMID:
15257013
12.

Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.

Siebenlist KR, Meh DA, Mosesson MW.

Thromb Haemost. 2001 Nov;86(5):1221-8.

PMID:
11816711
13.

The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.

Gorkun OV, Veklich YI, Weisel JW, Lord ST.

Blood. 1997 Jun 15;89(12):4407-14.

14.

Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Siebenlist KR, Mosesson MW, Hernandez I, Bush LA, Di Cera E, Shainoff JR, Di Orio JP, Stojanovic L.

Blood. 2005 Oct 15;106(8):2730-6. Epub 2005 Jul 7.

15.

Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization.

Moen JL, Gorkun OV, Weisel JW, Lord ST.

Blood. 2003 Oct 1;102(7):2466-71. Epub 2003 Jun 12.

16.

Control of anti-thrombogenic properties: surface-induced self-assembly of fibrinogen fibers.

Koo J, Galanakis D, Liu Y, Ramek A, Fields A, Ba X, Simon M, Rafailovich MH.

Biomacromolecules. 2012 May 14;13(5):1259-68. doi: 10.1021/bm2015976. Epub 2012 Apr 13.

PMID:
22423652
17.

Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering.

Laidmäe I, McCormick ME, Herod JL, Pastore JJ, Salum T, Sawyer ES, Janmey PA, Uibo R.

Biomaterials. 2006 Dec;27(34):5771-9. Epub 2006 Aug 21.

PMID:
16919721
18.

Fibrin sealants in clinical practice.

Albala DM.

Cardiovasc Surg. 2003 Aug;11 Suppl 1:5-11. Review.

PMID:
12869982
19.
20.
Items per page

Supplemental Content

Write to the Help Desk